Clinical Trial

The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People With HIV

Study acronym: EXPAND
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of The EXPAND study is to develop and pilot a pharmacist led model of medication delivery. Following a co-design phase, patients may receive injections at satellite pharmacies by a licensed pharmacist. The acceptability, appropriateness, and feasibility of this approach and standard in clinic administration by a nurse will be assessed.
Trial Details
NCT Number NCT06635421
Lead Sponsor MetroHealth Medical Center
Collaborators: ViiV Healthcare
Conditions HIV I Infection
Enrollment 164 participants
Start Date 2024-11-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-10